111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging

Emilio Bombardieri; Valentina Ambrosini; Cumali Aktolun; Richard P Baum; Angelica Bishof-Delaloye; Silvana Del Vecchio; Lorenzo Maffioli; Luc Mortelmans; Wim Oyen; Giovanna Pepe; Arturo Chiti; Oncology Committee of the EANM

doi:10.1007/s00259-010-1473-6

111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1441-8. doi: 10.1007/s00259-010-1473-6.

Authors

Emilio Bombardieri¹, Valentina Ambrosini, Cumali Aktolun, Richard P Baum, Angelica Bishof-Delaloye, Silvana Del Vecchio, Lorenzo Maffioli, Luc Mortelmans, Wim Oyen, Giovanna Pepe, Arturo Chiti; Oncology Committee of the EANM

Affiliation

¹ Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

PMID: 20461371
DOI: 10.1007/s00259-010-1473-6

Abstract

This document provides general information about somatostatin receptor scintigraphy with (111)In-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of (111)In-pentetreotide scintigraphy.

Publication types

Practice Guideline

MeSH terms

Female
Gamma Cameras
Gene Expression Regulation, Neoplastic
Humans
Image Interpretation, Computer-Assisted
Neoplasms / diagnostic imaging*
Neoplasms / genetics
Neoplasms / metabolism
Pregnancy
Quality Control
Radionuclide Imaging / instrumentation
Radionuclide Imaging / methods*
Receptors, Somatostatin / metabolism
Research Design
Somatostatin / administration & dosage
Somatostatin / analogs & derivatives*
Somatostatin / pharmacokinetics

Substances

Receptors, Somatostatin
Somatostatin
pentetreotide